Among these trials, one study aiming at hepatocellular carcinoma using a humanized monoclonal antibody against Dickkopf-1 (DKK1), DKN-01, is involved in phase I and II trials (ClinicalTrials.gov Identifier: NCT03645980). The gene discussed is DKK1; the disease is hepatocellular carcinoma.